Survodutide for the Treatment of Obesity: Baseline Characteristics of the SYNCHRONIZE Cardiovascular Outcomes Trial
- Platz E, Kaplan LM, le Roux CW, Wharton S, Burger S, Hussain SA, Brueckmann M, Startseva E, Fey C, Kosiborod MN, Bozkurt B. Survodutide for the Treatment of Obesity: Baseline Characteristics of the SYNCHRONIZE Cardiovascular Outcomes Trial JACC Heart Fail